Exhibit 4.2
|
CUSIP NO. 421915 EF 2
|
PRINCIPAL AMOUNT
|
$300,000,000
HEALTH CARE PROPERTY INVESTORS,
INC.
5.95% NOTES DUE
2011
THIS SECURITY IS A GLOBAL SECURITY
WITHIN THE MEANING SET FORTH IN THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF A
DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED
IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE
ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND,
UNLESS AND UNTIL IT IS EXCHANGED FOR SECURITIES IN DEFINITIVE FORM
AS AFORESAID, MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE
DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE
DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY
OR BY THE DEPOSITARY OR ITS NOMINEE TO A SUCCESSOR DEPOSITARY OR
ITS NOMINEE.
UNLESS THIS NOTE IS PRESENTED BY AN
AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY
(“DTC”), 55 WATER STREET, NEW YORK, NEW YORK TO THE
ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR
PAYMENT, AND SUCH NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE
& CO., OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC, ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR
VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, SINCE THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST
HEREIN.
HEALTH CARE PROPERTY INVESTORS,
INC., a Maryland corporation (the “Company”, which term
shall include any successor under the Indenture hereinafter
referred to), for value received, hereby promises to pay to CEDE
& CO., or registered assigns, the principal sum of Three
Hundred Million Dollars ($300,000,000) on September 15, 2011, and
to pay interest thereon from September 19, 2006 or from the most
recent interest payment date on which interest has been paid or
duly provided for, semi-annually in arrears on March 15 and
September 15 of each year (or if such date is not a Business Day,
on the next Business Day thereafter; no interest will accrue on
such payment for the period from and after such interest payment
date to the date of such payment on the next succeeding Business
Day) (each, an “Interest Payment Date”), commencing
March 15, 2007, at the rate of 5.95% per annum, until the entire
principal amount hereof is paid or duly provided for. The interest
so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in the Indenture, be paid
to the Holder in whose name this Note (or one or more predecessor
Notes) is registered at the close of business on the Regular Record
Date for such interest, which shall be the date that is 15 calendar
days prior to such Interest Payment Date, whether or not a Business
Day. Any such interest not so punctually paid or duly
provided for shall forthwith cease to be payable to the Holder on
such Regular Record Date, and may either be paid to the Holder in
whose name this Note (or one or more predecessor Notes) is
registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee,
notice whereof shall be given to Holders of Notes of this series
not less than 10 days prior to such Special Record Date, or may be
paid at any time in any other lawful manner not inconsistent with
the requirements of any securities exchange on which the Notes may
be listed, and upon such notice as may be required by such
exchange, all as more fully provided in the Indenture.
Interest will be computed on the basis of a 360-day year of twelve
30-day months. Payments of principal, premium, if any, and interest
in respect of this Note will be made by the Company in immediately
available funds.
Payment of the principal of and
interest on this Note shall be payable at the Corporate Trust
Office of The Bank of New York, located at 101 Barclay Street,
Floor 8 W, New York, New York 10286 or at such other office or
agency of the Company maintained for that purpose in The City of
New York, in such coin or currency of the United States of America
as at the time of payment is legal tender for payment of public and
private debts; provided, however, that, at the option of the
Company, interest may be paid by check mailed to the address of the
Person entitled thereto as such address shall appear on the
Security
Register or by transfer to an
account maintained by the payee with a bank located in the United
States; and, provided, further, that so long as this Note is
registered in the name of DTC or its nominee, principal and
interest payments will be paid to DTC or its nominee, as the
Holder, by wire transfer in same-day funds.
Reference is hereby made to the
further provisions of this Note set forth on the reverse hereof,
which further provisions shall for all purposes have the same
effect as if set forth at this place.
Unless the certificate of
authentication hereon has been executed by the Trustee by manual
signature of one of its authorized signatories, this Note shall not
be entitled to any benefit under the Indenture or be valid or
obligatory for any purpose.
IN WITNESS WHEREOF, the Company has
caused this instrument to be duly executed under its corporate seal
this 19th day of September, 2006.
|
|
Health Care Property Investors, Inc.,
|
|
|
a Maryland corporation
|
|
|
|
|
|
By:
|
|
|
|
Name:
|
Mark Wallace
|
|
|
Title:
|
Senior Vice President and Chief Financial
Officer
|
|
|
|
|
Attest:
|
|
|
|
|
|
By:
|
|
|
|
|
Name:
|
Edward J. Henning
|
|
|
Title:
|
Senior Vice President, General
Counsel
|
|
|
|
and Corporate Secretary
|
|
|
|
|
|
|
|
2
TRUSTEE’S CERTIFICATE OF
AUTHENTICATION:
This is one of the Notes of the
series designated herein referred to in the within-mentioned
Indenture.
|
The Bank of New York, as Trustee
|
|
|
|
By:
|
|
|
|
|
Authorized Signatory
|
|
|
|
|
|
|
Dated:
|
|
|
This Note is one of a duly
authorized issue of securities of the Company (herein called the
“Notes”), issued as a series of securities under an
indenture dated as of September 1, 1993 (the
“Indenture”), between the Company and The Bank of New
York, as trustee (the “Trustee,” which term includes
any successor trustee under the Indenture with respect to the
Notes), to which Indenture and all indentures supplemental thereto,
reference is hereby made for a statement of the respective rights,
limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Notes and of the terms
upon which the Notes are, and are to be, authenticated and
delivered. This Note is the duly authorized series designated as
the “5.95% Notes Due 2011,” originally limited (subject
to exceptions provided in the Indenture) in aggregate principal
amount to $300,000,000; however, from time to time, without giving
notice or seeking consent of the Holders of the Notes, the Company
may issue additional Notes of this series having the same ranking,
interest rate and maturity and other terms as this Note. All terms
used in this Note which are defined in the Indenture shall have the
meanings assigned to them in the Indenture.
If an Event of Default with respect
to the Notes shall occur and be continuing, the principal of the
Notes may be declared due and payable in the manner and with the
effect provided in the Indenture.
The Notes are not subject to any
sinking fund.
The Notes may be redeemed, in whole
or in part, at any time at the option of the Company at a
Redemption Price equal to the greater of: (1) 100% of the principal
amount of the Notes to be redeemed, or (2) the sum of the present
values of the remaining scheduled payments of principal and
interest thereon (exclusive of interest accrued to the Redemption
Date) discounted to the Redemption Date on a semi-annual basis
(assuming a 360-day year consisting of twelve 30-day months) at the
applicable treasury rate (as defined below) plus 20 basis points,
plus accrued and unpaid interest on the amount being redeemed to
the Redemption Date.
“Treasury rate” means,
with respect to any Redemption Date:
·
the yield, under the heading which represents the average for the
immediately preceding week, appearing in the most recently
published statistical release designated “H.15(519)” or
any successor publication which is published weekly by the Board of
Governors of the Federal Reserve System and which establishes
yields on actively traded U.S. Treasury securities adjusted to
constant maturity under the caption “Treasury Constant
Maturities,” for the maturity corresponding to the comparable
treasury issue (if no maturity is within three months before or
after the remaining life (as defined below), yields for the two
published maturities most closely corresponding to the comparable
treasury issue will be determined and the treasury rate will be
interpolated or extrapolated from such yields on a straight line
basis, rounding to the nearest month); or
·
if such release (or any successor release) is not published during
the week preceding the calculation date or does not contain such
yields, the rate per annum equal to the semi-annual equivalent
yield to maturity of the comparable treasury issue, calculated
using a price for the comparable treasury issue (expressed as a
percentage of its principal amount) equal to the comparable
treasury price for such Redemption Date.
3
The treasury rate will be calculated
by the Independent Investment Banker on the third Business Day
preceding the date fixed for redemption.
“Comparable treasury
issue” means the U.S. Treasury security selected by an
Independent Investment Banker as having a maturity comparable to
the remaining term (“remaining life”) of the Notes to
be redeemed that would be utilized, at the time of selection and in
accordance with customary financial practice, in pricing new issues
of corporate debt securities of comparable maturity to the
remaining term of such Notes.
“Comparable treasury
price” means (1) the average of five Reference Treasury
Dealer quotations for such Redemption Date, after excluding the
highest and lowest Reference Treasury Dealer Quotations, or (2) if
the Independent Investment Banker obtains fewer than four such
Reference Treasury Dealer Quotations, the average of all such
quotations.
“Independent Investment
Banker” means one of the Reference Treasury Dealers appointed
by the Company to act as the “Independent Investment
Banker.”
“Reference Treasury
Dealers” means each of Barclays Capital Inc., and J.P. Morgan
Securities Inc. and their respective successors and three other
nationally recognized investment banking firms that are Primary
Treasury Dealers specified from time to time by the Company;
provided, however, that if any of the foregoing shall cease to be a
primary US Government securities dealer in the United States (a
“Primary Treasury Dealer”), the Company shall
substitute therefor another nationally recognized investment
banking firm that is a Primary Treasury Dealer.
“Reference Treasury Dealer
Quotations” means, with respect to each Reference Treasury
Dealer and any Redemption Date, the average, as determined by the
Independent Investment Banker, of the bid and asked prices for the
comparable treasury issue (expressed in each case as a percentage
of its principal amount) quoted in writing to the Independent
Investment Banker at 5:00 p.m., New York City time, on the third
business day preceding such redemption date.
The Company may redeem the Notes in
increments of $1,000. If the Company redeems less than all of
the Notes, the Trustee will select the Notes to be redeemed using a
method it considers fair and appropriate. The Company will
cause notices of redemption to be mailed by first-class mail at
least 30 but not more than 60 days before the Redemption Date to
each Holder of Notes to be redeemed at its registered
address.
If this Note is